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Background: The morbidity of pancreatoduodenectomy remains high and the mortality may be signifi-
cantly increased in high-risk patients. However, a method to predict post-operative adverse outcomes
based on readily available clinical data has not been available. Therefore, the objective was to create a
‘Pancreatectomy Risk Calculator’ using the American College of Surgeons-National Surgical Quality
Improvement Program (ACS-NSQIP) database.
Methods: The 2005–2008 ACS-NSQIP data on 7571 patients undergoing proximal (n = 4621), distal
(n = 2552) or total pancreatectomy (n = 177) as well as enucleation (n = 221) were analysed. Pre-operative
variables (n = 31) were assessed for prediction of post-operative mortality, serious morbidity and overall
morbidity using a logistic regression model. Statistically significant variables were ranked and weighted
to create a common set of predictors for risk models for all three outcomes.
Results: Twenty pre-operative variables were statistically significant predictors of post-operative mor-
tality (2.5%), serious morbidity (21%) or overall morbidity (32%). Ten out of 20 significant pre-operative
variables were employed to produce the three mortality and morbidity risk models. The risk factors
included age, gender, obesity, sepsis, functional status, American Society of Anesthesiologists (ASA)
class, coronary heart disease, dyspnoea, bleeding disorder and extent of surgery.
Conclusion: The ACS-NSQIP ‘Pancreatectomy Risk Calculator’ employs 10 easily assessable clinical
parameters to assist patients and surgeons in making an informed decision regarding the risks and
benefits of undergoing pancreatic resection. A risk calculator based on this prototype will become
available in the future as on online ACS-NSQIP resource.
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Introduction
During the past decade, the number of pancreatic resections being
performed at high volumes centres has progressively increased.1
This change is multifactorial and includes increased detection of
malignant and premalignant pancreatic lesions, improved out-
comes at regional referral institutions and surgeons’ willingness to
operate on older and higher-risk patients. The annual number of
pancreatic resections has increased by 15% in the past 20 years,
and resection for benign pancreatic disease has increased by 27%.2
However, the morbidity of pancreatic surgery remains high, and
the mortality may be significantly increased in high-risk patients.
With a narrow therapeutic margin, careful patient selection is
imperative to minimize post-operative complications and opera-
tive mortality.
Single-institution studies have reported a low peri-operative
mortality rate of 1–2% for these procedures, but these results are
not always reproducible at other institutions.3–5 In contrast,
population-based studies have reported a higher peri-operative
mortality rate ranging from 4.6% to 7.8%.6,7 Morbidity after pan-
creatic resections still remains high with complication rates
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varying from 20% to 50%.8,9 Recently, The Nationwide Inpatient
Sample (NIS) has been used to develop both a nonogram and a
risk score to predict in-hospital mortality for cancer patients
undergoing pancreatectomy.10,11 These NIS-based analyses give
generalized estimates of national inpatient mortality rates for
patients after pancreatic resections for cancer. However, they do
not include estimates for other pancreatic diseases nor do they
provide information about the risk for developing post-operative
complications.
The American College of Surgeons-National Surgery Quality
Improvement Program (ACS-NSQIP) currently collects data on
pre-operative risk factors as well as post-operative morbidity and
mortality to assess surgical quality at more than 200 hospitals. The
NSQIP was first developed in Veterans Affairs hospitals in the
1990s12,13 and was then piloted in selected university medical
centres in the early 2000s.14 As the ACS-NSQIP has evolved, the
potential to provide robust outcomes on patients undergoing
pancreatic surgery and to develop risk calculators has become a
reality.15,16 Therefore, the objective of this analysis was to use the
ACS-NSQIP database to develop a pancreatectomy risk calculator
to predict post-operative adverse outcomes based on readily avail-
able clinical data.
Methods
ACS-NSQIP
The American College of Surgeons-National Surgical Quality
Improvement Program (ACS-NSQIP) is a prospective, multicen-
tre clinical registry that was created to provide feedback on risk-
adjusted outcomes to hospitals for quality-improvement
purposes. The sampling strategy, data abstraction procedures,
variables collected and structure have already been published.17–20
The programme collects detailed information on patient demo-
graphics, pre-operative risk factors and laboratory values, opera-
tive variables and post-operative events using standardized
definitions.12 From the ACS NSQIP database for 1 January 2005 to
31 December 2008, patients >16 years of age who underwent a
major pancreatic resection were identified using Current Proce-
dural Terminology (CPT) codes. These data were used for the
development of a pancreatectomy risk calculator.
Pre-operative variables
A set of potential predictive variables was constructed from ACS-
NSQIP data fields. The patient demographic variables of age
(<65, 65–74, 75–84 and >85 years) and gender, and the lifestyle
factor of smoking status (within 1 year of operation) and alcohol
status were considered. The pre-operative factors considered were
American Society of Anesthesiologists (ASA) classification (I/II,
normal healthy or mild systemic disease; III, severe systemic
disease; IV/V, severe systemic disease that is a constant threat to
life or moribund), pre-operative functional status (independent
vs. partially or totally dependent), dyspnoea (none, moderate
exertion, at rest) and body mass index (BMI) (normal, under-
weight, overweight, three levels of obesity as classified by the
World Health Organization). Comorbidities considered were ven-
tilator dependence, sepsis, a history of chronic obstructive pulmo-
nary disease (COPD), hypertension requiring medication, current
pneumonia, ascites, congestive heart failure (within 30 days prior
to the procedure), coronary heart disease (includes angina, myo-
cardial infarction within 30 days before the operation, percutane-
ous cardiac intervention, or coronary artery bypass surgery),
peripheral vascular disease (includes revascularization for periph-
eral vascular disease, claudication, rest pain, amputation, or gan-
grene) and a neurological event or disease (includes stroke with or
without residual deficit, transient ischaemic attack, haemiplegia,
paraplaegia, quadriplaegia, or impaired sensation), diabetes (oral
medication or insulin dependent), dialysis, acute renal failure,
weight loss (>10% in past 6 months), bleeding disorders, current
chemotherapy or recent radiotherapy, oesophageal varices,
chronic steroid use and red blood cell transfusion prior to the
procedure. All of these comorbidities are rigorously defined
within the ACS-NSQIP. A total of 31 pre-operative variables were
assessed for prediction of post-operative mortality, serious mor-
bidity, or overall morbidity.
Outcomes
Outcomes were assessed at 30 days regardless of whether the
patient was discharged, remained hospitalized or was admitted to
a different institution. Outcomes included mortality (all-cause
death within 30 days after the operation), serious morbidity and
30-day overall morbidity. Overall morbidity includes superficial
surgical site infection (without pre-operative wound infection),
deep incisional surgical site infection (without pre-operative
wound infection), pneumonia (without pre-operative pneumo-
nia), unplanned intubation (without pre-operative ventilator
dependence), progressive renal insufficiency (without pre-
operative renal failure or dialysis), urinary tract infection and
deep venous thrombosis. Variables that were assigned to serious
morbidity were organ space surgical site infection (without pre-
operative wound infection), wound disruption, cerebrovascular
accident or stroke, myocardial infarction, cardiac arrest requiring
cardiopulmonary resuscitation, pulmonary embolism, ventilator
dependence longer than 48 h (without pre-operative ventilator
dependence), acute renal failure (without pre-operative renal
failure or dialysis), bleeding complications defined by transfusions
in excess of four units and sepsis or septic shock (if pre-operative
sepsis exists, it must worsen post-operatively).
Risk calculator development
The risk calculator was developed after all pre-operative variables
were made categorical and entered with CPT codes and ICD-9
(International Classification of Disease Codes, 9th edition) codes.
CPT codes were used to categorize surgical procedure by extent or
type (proximal pancreatectomy, distal pancreatectomy, total pan-
createctomy or enucleation). The CPT codes used were 48140,
48145, 48146, 48150, 48152, 48153, 48154, 48155 and 48120. The
diagnoses were categorized according to the indication using
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ICD-9 codes: acute pancreatitis, chronic pancreatitis, benign neo-
plasm, malignant neoplasm or other. Operations were also classi-
fied by emergent/non-emergent procedures and wound class
(class 1/2: clean, clean/contaminated vs. class 3/4: contaminated or
dirty/infected).
Pre-operative laboratory variables examined included haemat-
ocrit, white blood count, platelet count, sodium, blood urea nitro-
gen, creatinine, albumin, partial thromboplastin time and
prothrombin. Values were categorized using ACS-NSQIP defini-
tions of normal and abnormal, and missing data constituted a
third categorical level, an indicator variable. Of note, all of the
laboratory values were forced into the model and were found not
to have a substantial impact on the overall determination of pre-
dictors for the risk calculator. Thus, they were not included in the
final risk calculator model.
Variables that entered the model for mortality included: age
group, systemic sepsis, functional health status, ASA classification,
history of congestive heart failure, dyspnoea, previous or concur-
rent chemotherapy, oesophageal varices and type of surgery. The
mortality model had four forced variables including gender, BMI
classification, coronary heart disease and bleeding disorder. Vari-
ables that entered the predictive model for morbidity included:
age group, gender, BMI classification, systemic sepsis, functional
status, ASA classification, surgical extent, coronary heart disease,
history of severe COPD, smoking status, dyspnoea, bleeding dis-
orders and weight loss greater than 10%.
Statistical analysis
All variables were converted to a categorical format. The statistical
model was constructed in two stages. First, forward stepwise logis-
tic regression models for mortality, serious morbidity and overall
morbidity were run which included all the independent variables
mentioned above.21 This modelling method adds variables to the
model when they provide significant, independent contributions.
A second step, the Firth penalized likelihood approach, was
needed in order to account for some predictors that have empty
cells as a result of a low occurrence rate or small sample sizes.22 For
example, mortality is an infrequent outcome and, when crossed
with certain predictors, may result in a cell that has no mortality
outcome under at least one level of the predictor. The presence of
these empty cells can compromise the validity of the ordinary
logistic model fitting algorithm. Firth’s penalized likelihood
approach was therefore used to achieve model consequence under
these empty cell conditions.22 However, as Firth’s method pre-
cludes step-wise methods, a two-step process was used where
step-wise selected variables were forced into Firth-adjusted
models for final parameter specifications.
Model quality was evaluated using Hosmer–Lemeshow
goodness-of-fit tests for calibration (correspondence in predic-
tions and observations across the range of predictions) and
c-statistics for discrimination.23,24 The c-statistic was considered
the most relevant measure of model success and refers to the
ability of the risk estimate to discriminate cases from non-cases. If
discrimination is no better than chance, the c-statistic will equal
0.50. All analysis and data manipulation were done using SAS 9.2
(SAS Institute, Inc., Cary, NC, USA).
Patient examples
To test the model and determine if it gave results similar to nation-
ally published data, we developed three example patients who fell
into low-, intermediate- and high-risk areas. The low-risk patient
was a 45-year-old female with a mucinous cyst neoplasm (MCN)
in the neck of the pancreas. This theoretical patient had an ASA
class of II, a BMI of 25 and no pre-operative sepsis. She is now
fully functional with no coronary heart disease, no dyspnoea or
bleeding disorders. The pre-operative plan is enucleation of the
MCN. The intermediate risk patient was a 75-year-old male with
an intraductal papillary mucinous neoplasm (IPMN) in the tail of
the pancreas. He has a BMI of 35, an ASA class of III, no pre-
operative sepsis and is fully functional. He had a prior coronary
artery bypass graft but did not have dyspnea or bleeding disorders.
He is scheduled for a laparoscopic distal pancreatectomy. The
high-risk patient was a 55-year-old male with chronic pancreatitis
as a result of excess alcohol intake. He has chronic pain requiring
narcotics and a distal bile duct stricture which was stented endo-
scopically. This patient has a BMI of 30, sepsis because of cholan-
gitis, is dependent in an intensive care unit, has an ASA class of IV,
had a prior coronary angioplasty, dyspnea with moderate exertion
and has a bleeding disorder. His surgeon is contemplating a pan-
creatoduodenectomy for relief of pain and biliary obstruction.
Results
Patient characteristics
The 2005 to 2008 ACS-NSQIP dataset yielded 7571 pancreatic
procedures at 193 hospitals (Table 1). The average patient age was
61.9 years with 47.7% being male. ASA Class III was most
common (60.8%). The most frequent procedure was a proximal
pancreatectomy at 61.0%, and the most common indication was
neoplasm at 66.5%. Mortality was 2.5%, serious morbidity was
21.2% and overall morbidity was 31.8%.
The individual mortality rates for the procedures were 2.9% for
proximal pancreatectomy, 1.7% for distal pancreatectomy, 0.4%
for pancreatic enucleation and 4.8% for total pancreatectomy.
Risk calculator
Application of the variable selection process for the dataset
yielded six variables that appeared in models for all three out-
comes and five variables that appeared in two outcomes (Table 2).
One variable, coronary heart disease, was only involved in one
model but had significant impact and early selection and therefore
was considered to be important enough to be entered into the
dataset. Based on entry into individual models, the 10 variables
which were most highly weighted and found to have the highest
rank in all three models, were chosen as the universal data set to
develop the pancreatic risk calculator. Odds ratios for the variables
selected for the universal model showed findings consistent with
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clinical expectations (Table 3). The relative odds ratios for age and
surgical extent are illustrated in Fig. 1a,b, respectively. Models
using the 10-variable universal dataset had acceptable discrimina-
tion and calibration for each outcome (Table 4). The c-statistics
for mortality, serious morbidity and overall morbidity were 0.74,
0.61 and 0.61, respectively, and the Hosmer–Lemoshow fit statis-
tics were not significant, indicating that the model had adequate
fit for the variables entered.
Patient examples
The patient examples that were entered into the model showed
levels of mortality, serious morbidity and overall morbidity com-
parable to most literature on this topic (Table 5, Fig. 2). The low-
risk patient who had no abnormal variables and received a
pancreatic enucleation for a benign neoplasm had a risk of mor-
tality, serious morbidity and overall morbidity of 0.08%, 12.6%
and 18.6%, respectively. The intermediate-risk patient who had
four abnormal variables and received a distal pancreatectomy for
an IPMN had a 2.1% risk of mortality. The risk for serious mor-
bidity and overall morbidity were higher at 23% and 32.6%. The
high-risk patient who had eight abnormal variables and was being
considered for a proximal pancreatectomy had a mortality risk of
33.6%, with a risk of serious morbidity at 77.2% and overall
morbidity at 87.6%.
Discussion
The ACS-NSQIP dataset from 2005–08 had 7571 patients who
had undergone a pancreatic resection. Thirty-one preoperative
variables were analysed for prediction of post-operative mortality,
serious morbidity and overall morbidity using logistic regression
models. Twenty pre-operative variables were found to be statisti-
cally significant. Ten out of the 20 risk factors were employed to
produce mortality and morbidity risk models. The risk factors
included age >74 years, male gender, BMI higher than 40, pre-
operative sepsis, dependent functional status, ASA class more than
II, history of coronary heart disease, dyspnoea on moderate exer-
tion, a bleeding disorder and the contemplated procedure
(Table 6). All of these variables can be easily assessed at the time of
initial presentation and entered into the model so that a surgeon
can provide an accurate assessment of operative risk, and a patient
can receive individualized estimates of the risk of mortality,
serious morbidity and overall morbidity.
Patients who present with pancreatic pathology are often
elderly and have multiple medical comorbidities. During initial
evaluation, while performing a patient’s history and physical, the
comorbidities in the Pancreatectomy Risk Calculator can be iden-
tified and can be used to determine if the patient is an appropriate
candidate for surgery. During this pre-operative counselling, the
risk and benefits of the procedure are explained, and consent is
obtained. Currently, the pre-operative counselling needed to
obtain informed consent includes knowledge of published peri-
operative morbidity and mortality rates. However, the majority of
this information comes from referral centres and is not individu-
alized for a particular patient. The Pancreatectomy Risk Calcula-
tor that was developed from the ACS-NSQIP database uses
variables that can easily be discovered by a careful history and
physical examination and will be available online as an ACS-
NSQIP resource. This information also may be employed to plan
resources for the patient and might be used to encourage risk
stratification.
Predictive models that calculate the risk of post-operative mor-
tality after pancreatectomy for cancer have been developed using
the Nationwide Inpatient Sample.10,11 The NIS is managed by the
Healthcare Cost and Utilization Project and is the largest all-payer
database of hospital discharges, providing a 20% stratified sample
of all non-federal hospitals in a given year. The data for the hos-
pital and patients are entered retrospectively after discharge of the
patient using ICD-9 codes. The integer-based risk score that was
developed from the NIS uses age, gender, Charlson comorbidity
Table 1 Patient demographics in ACS-NSQIP used for pancreatec-
tomy risk calculator
Variable 2005–2008
n 7571
Hospitals, n 193
Cases/hospital, n (range) 39.2 (1–519)
Age, years,a mean  SD 61.9  13.8
Gender, % male 47.7
ASA, %
I/II. Normal healthy/Mild systemic disease 34.7
III. Severe systemic disease 60.8
IV/V. Severe systemic disease/Moribund 4.5
Surgical extent, %
Proximal pancreatectomy 61.0
Distal pancreatectomy 33.7
Enucleation 2.9
Total pancreatectomy 2.3
Indication for surgery, %b
Malignant neoplasm 66.5
Benign neoplasm 18.5
Chronic pancreatitis 5.0
Acute pancreatitis 1.3
Other 8.7
Outcomes
Mortality 2.5
Serious morbidity 21.2
Overall morbidity 31.8
aAge recorded as 90+ had been recorded to 90.
bTaken from the reported ICD-9 code for post-operative diagnosis in ACS
NSQIP.
ACS NSQIP, American College of Surgeons National Quality Improve-
ment Program; ASA, American Society of Anesthesiologists Physical
Status Classification.
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score, pancreatectomy type and hospital volume as its predictors
for in-patient mortality for patients with pancreatic adenocarci-
noma.10 This model may be able to predict in-patient mortality;
however, it does not have the ability to predict serious morbidity
and overall morbidity. With published reports showing that mor-
bidity for pancreatic resections varies from 20% to 50%, the
chance of developing a post-operative complication is important
for patients to appreciate prior to pancreatic resection.25
Nonograms are graphical devices or models that use algorithms
or mathematical formulae to estimate the probability of an
outcome for each individualized patient. The benefit of post-
operative nonograms in predicting long-term survival has been
proven in patients with cancers of various organ systems.
Recently, a nonogram has been developed to preoperatively
predict in-patient mortality for patients after pancreatic resection
using the Nationwide Inpatient Sample (NIS).10 This nonogram
has similar limitations as the integer-based risk score. Important
factors that might contribute to peri-operative risk such as ASA
class, functional status, weight loss, coronary heart disease and
serum albumin are not available in the NIS. Furthermore, the
nonogram, while web accessible, has numerous questions that
need to be answered, making it lengthy and cumbersome for use.
In comparing the ACS-NSQIP Pancreatectomy Risk Calculator to
the NIS Risk Score and Nonogram, the Risk Calculator employed
more patients (7571 vs. 5481 or 5715), over a shorter time (4 vs. 6
or 9 years), with more diagnoses (all vs. cancer) and procedures
(all vs. major).
In recent years, considerable attention has been given to using
computer-based methods to classify medical data to help predict
outcomes. The general approach has been to develop computer
algorithms that learn decision characteristics for data classifica-
tion and then use them to classify future patients with unknown
disease states or therapy outcomes. Several quantitative models
ranging from simple linear analysis to more complex logistic
regression and artificial neural networks (ANN) have been pro-
posed. ANN is based on finding an optimal path from the sample
space to the decision space. This process involves feeding unique
input samples (features) and the matching responses (outcomes)
to let the network learn from the examples and compose a map
that inter-relates inputs to outputs through a complex set of inter-
connecting pathways or operations.26 Unlike logistic regression,
which fits the data to a descriptive function, ANN transforms the
data on each layer, changing its dimensional space to define the
rule to get to the decision region. Thus, the two approaches are
inherently different, raising the question if one approach has
better diagnostic performance than the other. A meta-analysis
comparing ANN with regression models in 28 studies found
that both modes have similar performance.27 In another study,
Table 2 Variables selected in construction of the pancreatectomy risk calculator
ACS NSQIP variablesa Mortalityb Serious
morbidityb
Overall
morbidityb
Models, n Included in
universal model
ASA classification 2 2 1 3 Yes
Functional health status 1 3 4 3 Yes
Sepsis 6 1 2 3 Yes
Surgical extent 5 6 3 3 Yes
Age group 3 8 8 3 Yes
Dyspnoea 4 5 11 3 Yes
Body mass index 7 7 2 Yes
Coronary heart disease 5 1 Yes
Gender 4 12 2 Yes
Bleeding disorder 11 6 2 Yes
Oesophageal varices 8 13 2 No
COPD 12 9 2 No
Congestive heart failure 7 1 No
Chemotherapy 9 1 No
Wound class 9 1 No
Peripheral vascular disease 10 1 No
Smoking status 10 1 No
Weight loss 13 1 No
Ascites 14 1 No
Neurological disease 14 1 No
aSome variables have been restructured. bSelection order.
ACS NSQIP, American College of Surgeons National Quality Improvement Program; ASA, American Society of Anesthesiologists Physical Status
Classification; COPD, chronic obstructive pulmonary disease.
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Dreiseitl surveyed 72 articles comparing ANN with logistic regres-
sion and found there was no difference in models for predicting
outcomes.28 Currently, only one paper uses ANN for predicting
clinical outcomes in patients with acute biliary pancreatitis and
none for pancreatic surgery.29
A recent analysis of complication rates after pancreatectomy
again employing the Nationwide Inpatient Sample also has been
published.30 This analysis reported a 22.7% complication rate after
pancreatectomy with no change over the 9 years of the analysis
(1998–2006). Independent predictors of complications include
age >74 years, total pancreatectomy, and low hospital resection
volume. In comparison, the ACS-NSQIP Pancreatectomy risk Cal-
culator provides robust information for prediction of both serious
and overall morbidity with more recent clinical rather than
administrative data.
The potential benefit of undergoing resection at high-volumes
centres has led to regionalization of care for patients with pancre-
atic malignancies.1,31–33 However, contradictory data exist as to
what defines high volume and whether volume should be defined
by surgeon volume or hospital volume.34,35 A study using the
Nationwide Inpatient Sample showed that volume alone
accounted for less than 2% of the variance in peri-operative mor-
tality after pancreatic resection.35 Furthermore, the Nationwide
Inpatient Sample only provides information on hospital volume
but is not able to provide surgeon specific data. The ACS-NSQIP
has the potential to adjust outcomes by hospital volume and
individual surgeon. Analyses of these options are underway
but are not represented in the present. In this study of the 193
hospitals, 60% were academic/teaching institutions which could
be described as high-volume hospitals for pancreatic resections.
Table 3 Percentages, odds ratios and confidence intervals for variables in pancreatectomy risk calculator
ACS NSQIP variablesa % of patients Mortality Serious morbidity Overall morbidity
Age (<65 years) 53.3
65–74 years 27.1 1.70 (1.17–2.47)b 1.10 (0.96–1.26)b 1.13 (1.00–1.27)b
75–84 years 17.6 2.28 (1.54–3.38) 1.30 (1.11–1.51) 1.26 (1.10–1.45)
85 years 2.0 3.54 (1.77–7.05) 1.57 (1.08–2.27) 1.78 (1.27–2.49)
Gender Male 47.7 1.16 (0.86–1.57) 1.22 (1.09–1.37)b 1.13 (1.02–1.25)c
Body mass index (normal) 36.4
Underweight 3.4 0.96 (0.40–2.33) 0.94 (0.67–1.31)b 0.95 (0.71–1.26)b
Overweight 34.8 1.29 (0.91–1.83) 1.15 (1.00–1.31) 1.16 (1.02–1.30)
Class 1 obesity 15.7 1.28 (0.82–2.02) 1.34 (1.13–1.58) 1.34 (1.16–1.56)
Class 2 obesity 6.1 0.91 (0.44–1.91) 1.22 (0.96–1.56) 1.24 (1.00–1.53)
Class 3 obesity 3.7 2.32 (1.17–4.63) 1.83 (1.38–2.44) 1.60 (1.23–2.09)
Sepsis 3.0 2.62 (1.30–3.95)b 2.26 (1.70–3.01)b 2.10 (1.60–2.79)b
Functional health status
(dependent)
3.3 3.27 (2.05–5.21)b 1.73 (1.30–2.29)b 1.75 (1.33–2.30)b
ASA classification I/II (no/mild
disturbance)
34.7
Class III (severe
disturbance)
60.8 2.33 (1.49–3.64)b 1.18 (1.03–1.34)c 1.20 (1.06–1.33)b
Life-threatening/moribund 4.5 3.20 (1.70–6.03) 1.33 (1.01–1.75) 1.40 (1.09–1.80)
Coronary heart disease 10.8 1.18 (0.80–1.73) 1.20 (1.01–1.43)c 1.26 (1.08–1.48)b
Dyspnoea 9.2
Moderate exertion 8.4 1.72 (1.15–2.58)b 1.38 (1.14–1.66)b 1.36 (1.14–1.61)b
At rest 0.8 4.70 (2.15–2.58) 1.44 (0.82–2.53) 1.08 (0.63–1.86)
Bleeding disorder 2.9 1.15 (0.58–2.29) 1.43 (1.06–1.94)c 1.68 (1.27–2.23)b
Surgical extent (proximal) 61.0
Distal pancreatectomy 33.7 0.62 (0.43–0.88)b 0.77 (0.68–0.88)b 0.73 (0.66–0.82)b
Enucleation 2.9 0.10 (0.01–1.52) 0.74 (0.52–1.06) 0.63 (0.46–0.87)
Total pancreatectomy 2.3 1.86 (0.91–3.79) 1.07 (0.74–1.53) 0.91 (0.66–1.27)
aSome variables have been restructured.
bP-values < 0.01.
cP-values < 0.001 for the variable.
ACS NSQIP, American College of Surgeons National Quality Improvement Program; ASA, American Society of Anesthesiologists Physical Status
Classification.
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Figure 1 (a) Odds ratios for increasing patient age in predicting mortality. (b) Odds ratios for the four pancreatectomy procedures
Table 4 Model performance for pancreatectomy risk calculator
Model performance Mortality Serious morbidity Overall morbidity
Rate (n, %) 186 (2.5) 1605 (21.2) 2411 (31.8)
C-statistic 0.74 0.61 0.61
Hosmer–Lemeshow 0.28 0.61 0.79
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Furthermore, the average number of cases per hospital was 39
with the range from 1 case to 519 cases over that time period.
This study has several limitations. The ACS-NSQIP database
only includes information from 2005–08 and from fewer than 200
hospitals nationwide. However, these institutions perform the
majority of pancreatic surgery in the United States. In the 4-year
period, 7571 pancreatic resections were performed and included
in the development of the pancreatic risk calculator. Because of
the limited number of pancreatic resections, the pancreatic risk
model has not been validated with any subsequent data. The
present plan is to carry out analyses of 2009 and future data for
validation of this model. Being able to further evaluate both
hospital- and surgeon-specific data would help to further deter-
mine patient outcome. Another limitation of the present study is
the inability to define the frequency and morbidity related to
operation-specific complications. For example, a major contribu-
tor to surgical site infection after pancreatectomy is pancreatic
leak. A pancreatic fistula occurs in approximately 10% to 15%
of pancreatoduodenectomy36 and 30% of distal pancreatectomy
patients.37,38 In this current dataset, pancreatic fistula is grouped
with other organ space infections. However, in an upcoming
update to the ACS-NSQIP data structure pancreatectomy-specific
pre-operative risk factors and post-operative outcomes will be
collected. Having data on pancreatectomy-specific outcomes such
as pancreatic fistula will be very helpful in determining the cause
and improving outcomes.
Despite these limitations, the purpose of the present study was
to develop a Pancreatectomy Risk Calculator using variables that
are easily obtainable by history and physical examination. The
Pancreatectomy Risk Calculator is not intended to substitute for
surgeon judgment or experience but should be used as an addi-
tional resource in counselling patients who are being considered
Table 5 Patients tested with pancreatectomy risk calculator
Patient performance Mortality Serious morbidity Overall morbidity
Low risk 0.08% 12.6% 18.6%
Intermediate risk 2.1% 23.0% 32.6%
High risk 33.6% 77.2% 87.6%
Risk
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 c
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20
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100
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Figure 2 Outcomes in low-, intermediate- and high-risk patients
Table 6 Risk factors for increased mortality, serious morbidity and
overall morbidity
Age > 74
Gender Male
BMI > 40
Preoperative sepsis
Dependent functional health status
ASA classification > II
Coronary heart disease
Dyspnoea on moderate exertion
Bleeding disorder
Proximal or total pancreatectomy
BMI, body mass index.
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for high-risk pancreatic surgery. In the future ACS-NSQIP data
will also provide increasingly specific data at the hospital-,
surgeon- and procedure-specific levels. In summary, the ACS-
NSQIP Pancreatectomy Risk Calculator employs 10 easily acces-
sible clinical parameters to assist patients and surgeons in
making an informed decision regarding risks and benefits of
pancreatic resection. This system also may be helpful in resource
planning and risk modification. A risk calculator based on this
prototype will soon become available as an online ACS-NSQIP
resource.
Disclosure of interest
None declared.
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